POPULARITY
153 episodes with abcp
6 episodes with abcp
2 episodes with abcp
8 episodes with abcp
7 episodes with abcp
3 episodes with abcp
2 episodes with abcp
Cláudia Lemos, jornalista e servidora da Câmara dos Deputados, é uma referência na comunicação pública. Com mais de 30 anos de experiência e uma trajetória que inclui a presidência da ABCPública por 4 anos, ela compartilha os itens essenciais do seu Kit de Sobrevivência: posturas, práticas, dica de leitura e tudo o mais que a ajuda a navegar pelos desafios da área.Link para inscrição no bate-papo citado durante o episódio:https://doity.com.br/comunicacao-publica-em-2025-modos-de-fazer.
US Short Duration strategists Teresa Ho and PJ Vohra provide an update in the equity financing markets and discuss how that is driving growth in the ABCP market. Speakers Teresa Ho, Head, U.S. Short Duration Strategy Pankaj Vohra, U.S. Short Duration Strategy This podcast was recorded on March 7, 2025. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4902017-0 and https://www.jpmm.com/research/content/GPS-4926314-0 for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2025 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P. Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to prevent any and all access to or use of such J.P. Morgan Data by any third-party.
Nesta pílula, listo alguns cursos e congressos de comunicação previstos para 2025.Para entrar em contato comigo e se cadastrar no mailing:www.alinecastrocomunica.com.br14º Redes WeGovOrganização: WeGovFormato: Presencial, em FlorianópolisDuração: 29 e 30 de abrilDescrição: o evento visa promover a troca de conhecimentos e experiências entre profissionais do setor público, acadêmicos e especialistas em governança, tecnologia e inovação.Link:https://wegov.com.br/14-redes-wegov/Programa Avançado em Comunicação Pública 2025Organização: ABCPública em parceria com a AberjeFormato: OnlineDuração: 60 horas, em 10 módulosPeríodo: De 17 de maio a 1º de novembro de 2025Descrição: Este curso é voltado para profissionais da área pública e aborda temas como linguagem simples, estratégia e planejamento, comunicação digital, gestão de crises, entre outros. Cada módulo traz especialistas renomados e inclui debates.Link:https://abcpublica.org.br/curso-completo/III Congresso Brasileiro de Comunicação Pública (ComPública)Data: 20 a 22 de outubro de 2025Local: Universidade Federal de Sergipe (UFS), Aracaju, SETema: "Emergência Climática e Direito à Informação"Descrição: Este congresso é uma iniciativa da ABCPública em parceria com a UFS. Durante três dias, profissionais, pesquisadores e estudantes discutirão práticas de comunicação pública e suas relações com cidadania, direitos humanos e democracia. A programação tem palestras, mesas-redondas e apresentações de artigos científicos.Link: abcpublica.org.brPós-graduação Comunicação em Saúde (PUC-Minas)Formato: Online, aulas assíncronasDuração: 432 horas/aula (equivalente a 360 horas)Período:Liberação das aulas em 24/03/2025.Descrição: A especialização em Comunicação em Saúde associa teoria e prática e proporciona conhecimento sobre o sistema de saúde brasileiro, legislação, planejamento e tecnologias inteligentes que aumentam a efetividade na comunicação e gestão. A comunicação é apresentada como direito, estratégia e ferramenta para interface com a alta gestão das organizações e fortalecimento da cidadania.Link:puc-minasPós-graduação Comunicação Pública e Governamental (PUC-Minas)Formato: OnlineDuração: 432 horasPeríodo: De 8 de abril de 2025 a 18 de junho de 2026Descrição: O curso visa suprir lacunas na formação de profissionais de comunicação, qualificando-os para atuar na esfera pública. Aborda conceitos e contextos, além de ferramentas aplicáveis em áreas como jornalismo e relações públicas.Link:puc-minas48º Congresso Brasileiro de Ciências da Comunicação (Intercom 2025)Etapa Remota: 11 a 16 de agosto de 2025Etapa Presencial: 1 a 5 de setembro de 2025Local da Etapa Presencial: Centro Universitário FAESA, Vitória, ESTema: "(Re)pensar a Comunicação - ensino, pesquisa e extensão"Descrição: Organizado pela Sociedade Brasileira de Estudos Interdisciplinares da Comunicação (Intercom), este congresso anual reúne milhares de participantes para debater tópicos como jornalismo, relações públicas, publicidade, rádio, televisão, produção editorial e políticas públicas de comunicação.Link: portalintercom.org.br11º Congresso da Associação Brasileira de Pesquisadores em Comunicação e Política (Compolítica)Data: 14 a 16 de maio de 2025Local: Unicap, Recife, PETema: "Ciência Aberta, Humanidades Digitais e monetização de dados: desafios democráticos e epistemológicos para a pesquisa em Comunicação e Política"Descrição: Este congresso promove debates sobre temas emergentes na interface entre comunicação e política, com foco em ciência aberta e humanidades digitais. Link: congresso2025.compolitica.orgIntercom Sudeste 2025Data: 15 a 17 de maio de 2025Local: PUC-CampinasTema: "(Re)pensar a Comunicação como conhecimento, formação e práticas profissionais"Descrição: Este congresso regional reúne pesquisadores, profissionais e estudantes da área de comunicação para discutir temas relevantes e compartilhar pesquisas.Link: intercomsudeste2025.com.br
Nesta pílula, listo alguns cursos e congressos de comunicação previstos para 2025.Para entrar em contato comigo e se cadastrar no mailing:www.alinecastrocomunica.com.brPrograma Avançado em Comunicação Pública 2025Organização: Associação Brasileira de Comunicação Pública (ABCPública) em parceria com a Associação Brasileira de Comunicação Empresarial (Aberje)Formato: Online, via ZoomDuração: 60 horas, divididas em 10 módulosPeríodo: De 17 de maio a 1º de novembro de 2025Descrição: Este curso é voltado para profissionais da área pública e aborda temas como linguagem simples, estratégia e planejamento, comunicação digital, gestão de crises, entre outros. Cada módulo é ministrado por especialistas renomados e inclui palestras, seminários e debates.Link:https://abcpublica.org.br/curso-completo/III Congresso Brasileiro de Comunicação Pública (III ComPública)Data: 20 a 22 de outubro de 2025Local: Universidade Federal de Sergipe (UFS), Campus São Cristóvão, Aracaju, SETema: "Emergência Climática e Direito à Informação"Descrição: Este congresso é uma iniciativa da Associação Brasileira de Comunicação Pública (ABCPública) em parceria com a UFS. Durante três dias, profissionais, pesquisadores e estudantes discutirão práticas de comunicação pública e suas relações com cidadania, direitos humanos e democracia. A programação incluirá palestras, mesas-redondas e apresentações de artigos científicos.Link: abcpublica.org.brPós-graduação Comunicação em Saúde (PUC-Minas)Formato: Online, aulas assíncronasDuração: 432 horas/aula (equivalente a 360 horas)Período:Liberação das aulas em 24/03/2025.Descrição: A especialização em Comunicação em Saúde associa teoria e prática e proporciona conhecimento sobre o sistema de saúde brasileiro, legislação, planejamento e tecnologias inteligentes que aumentam a efetividade na comunicação e gestão. A comunicação é apresentada como direito, estratégia e ferramenta para interface com a alta gestão das organizações e fortalecimento da cidadania.Link:puc-minasPós-graduação Comunicação Pública e Governamental (PUC-Minas)Formato: OnlineDuração: 432 horasPeríodo: De 8 de abril de 2025 a 18 de junho de 2026Descrição: O curso visa suprir lacunas na formação de profissionais de comunicação, qualificando-os para atuar na esfera pública. Aborda conceitos e contextos, além de ferramentas aplicáveis em áreas como comunicação digital, jornalismo e relações públicas.Link:puc-minas48º Congresso Brasileiro de Ciências da Comunicação (Intercom 2025)Etapa Remota: 11 a 16 de agosto de 2025Etapa Presencial: 1 a 5 de setembro de 2025Local da Etapa Presencial: Centro Universitário FAESA, Vitória, ESTema: "(Re)pensar a Comunicação - ensino, pesquisa e extensão"Descrição: Organizado pela Sociedade Brasileira de Estudos Interdisciplinares da Comunicação (Intercom), este congresso anual reúne milhares de participantes para debater tópicos como jornalismo, relações públicas, publicidade, rádio, televisão, cinema, produção editorial e políticas públicas de comunicação.Link: portalintercom.org.br11º Congresso da Associação Brasileira de Pesquisadores em Comunicação e Política (Compolítica)Data: 14 a 16 de maio de 2025Local: Universidade Católica de Pernambuco (Unicap), Recife, PETema: "Ciência Aberta, Humanidades Digitais e monetização de dados: desafios democráticos e epistemológicos para a pesquisa em Comunicação e Política"Descrição: Este congresso promove debates sobre temas emergentes na interface entre comunicação e política, com foco em ciência aberta e humanidades digitais. Link: congresso2025.compolitica.orgIntercom Sudeste 2025Data: 15 a 17 de maio de 2025Local: PUC-Campinas - Campinas, SPTema: "(Re)pensar a Comunicação como conhecimento, formação e práticas profissionais"Descrição: Este congresso regional reúne pesquisadores, profissionais e estudantes da área de comunicação para discutir temas relevantes e compartilhar pesquisas.Link: intercomsudeste2025.com.br
Quando o assunto é inteligência artificial, existem dois tipos de pessoas: os que amam e usam diariamente e os que ainda têm receio ou desconhecem as ferramentas. Para todos os casos, é importante conhecer mais sobre riscos e boas práticas para utilizarmos a IA com ética e responsabilidade. Nessa pílula, Fernando Souza, profissional responsável pela redação da Recomendação sobre IA publicada pela ABCPública, traz detalhes sobre o documento e faz alertas sobre o uso dessas ferramentas no âmbito da comunicação pública no Brasil. Para acessar o documento completo, clique aqui: https://abcpublica.org.br/biblioteca/recomendacao-no-1/
In this JCO Article Insights episode, Rohit Singh provides summary on two articles published in the April 10th issue of the Journal of Clinical Oncology. The first article, "Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)" describes a randomized, open-label, multicenter, phase III study evaluating the efficacy of atezolizumab plus bevacizumab, paclitaxel, and carboplatin (ABCP ) in EGFR- or ALK-mutated NSCLC that progressed before TKI therapy. The second is the accompanying Oncology Grand Rounds. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Rohit Singh: Hello and welcome to JCO Article Insights. I'm your host, Dr. Rohit Singh. Today I will provide a summary of a Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04), by Dr. Park and colleagues from Seoul, Korea. The purpose of this study was to evaluate the efficacy and safety of the ABCP regimen based on IMpower150 in patients with EGFR or ALK mutated non-small cell lung cancer who had progressed on prior targeted treatment. I will also discuss an Oncology Grand Round case titled "Management of Treatment Resistance in Patients with Advanced EGFR Lung Cancer: Personalization, Parsimony, and Partnership", by Dr. Vallillo and colleagues from Lahey Hospital Medical Center and Tufts University School of Medicine, Boston, Massachusetts. Oncology Grand Round cases help us to give a clinical context to the clinical trial. While TKIs are the established standard of care for non-small cell lung cancer harboring driver mutations, most patients will develop resistance to these treatments. Immune checkpoint inhibitors, with or without chemo, have shown clinical benefits of immune checkpoint monotherapy in patients with EGFR-mutated non-small cell lung cancer. Consequently, platinum-based chemo is the standard of care for patients with EGFR TKI failure. This was a phase III, multicenter, open-label, randomized trial conducted at 16 hospitals across the Republic of Korea. Patients diagnosed with stage four non-small cell lung cancer with sensitizing EGFR mutation or ALK translocation were included in the study. Patients were randomly assigned to the ABCP arm or chemo-only arm in a 2:1 ratio. Eligible patients were stratified on the mutation type (EGFR mutation vs. ALK translocation) and the presence of brain metastasis. No crossover to atezolizumab was permitted. The recruitment with T790M mutation was capped at 30%. Patients who responded continued to receive maintenance with atezolizumab until disease progression or unacceptable toxicities occurred. If a patient was identified to have an acquired T790M mutation after the failure of a first or second-generation EGFR TKI, the patient had to be treated with a third-generation EGFR TKI before enrollment. The primary endpoint was investigator-assessed objective response rate according to research criteria. The secondary endpoints included overall survival and progression-free survival at one and two years, and the duration of response, along with a safety analysis. Investigators also did an exploratory biomarker analysis based on PD-L1 expression and its correlation with the response. They also analyzed the distribution of tumor-infiltrating lymphocytes, and a cut-off of 20% inflamed score was used to compare the two arms. Overall, 228 patients were enrolled, 154 in the ABCP arm and 74 in the chemo-only arm. Most patients were female at 56.1% and never smokers at 62.7%. Brain metastasis was present in 42.7% of patients. Most patients had previously received EGFR TKI therapy, however, only 8% and 30% received third-generation TKI as first-line therapy in the ABCP arm and chemo-only arm, respectively. The majority of the patients were EGFR at 90%. The median duration of follow-up for the study population was 26 months. The objective response rate in the ABCP arm was significantly higher at 69.5% compared to 42% in the chemotherapy alone arm. The median PFS was significantly longer in the ABCP arm at 8.48 months versus 5.6 months, and the duration of response was similar at around seven months in both arms. The median overall survival was also similar at around 20 months in both arms, with a hazard ratio of 1.01. In the subgroup of patients with brain metastasis at the time of study enrollment, PFS was significantly longer in the ABCP arm at 8.4 months compared to 4.4 months in the chemotherapy-only arm. In contrast, no difference in PFS was observed in the subgroup without brain metastasis. Regarding EGFR mutation status, there was no difference in PFS or OS between the two arms in the EGFR deletion 19 subgroup. However, a favorable PFS was observed in the EGFR L858R subgroup. For those with acquired EGFR T790M mutation, there was no difference in PFS between groups, whereas a favorable PFS was observed in the subgroup without EGFR T790M mutation. In the exploratory biomarker analysis, interestingly, the impact on PFS was correlated with PD-L1 expression. The study found that the higher the PD-L1 expression, the better the PFS. In patients with PD-L1 expression of more than 50%, the hazard ratio was 0.24 for PFS. This is an interesting observation. As in previous studies, we have seen that PD-L1 expression does not have a strong association with response to checkpoint inhibitors in patients with driver mutations. Based on the distribution density of tails in the tumor bed, the inflamed score was calculated using artificial intelligence. For patients with 20% of the imflamed score, the ABCP arm has significantly prolonged PFS at 12.9 months compared to 4.8 months. The median number of ABCP treatment cycles was 4, with 12 for atezolizumab and 8 for bevacizumab as maintenance therapy, pemetrexed maintenance was administered for a median of 10 cycles. The incidence of grade 3 or higher side effects was 35.1% in the ABCP arm compared to 15% in the chemotherapy-only arm. Peripheral neuropathy, alopecia, and myalgias were the most prevalent side effects. Interesting notably, 54% of patients in the ABCP arm required treatment interruption or dose modification, and there were three reported deaths in the ABCP arm, two due to pneumonia and one due to cerebral embolic infarction. Around 10 patients or 13.5% of patients in the chemotherapy-only arm required dose interruption or modification. In conclusion, patients with EGFR-mutated or translocated non-small cell lung cancer who had failed prior TKI ABCP regimen showed a statistically significant prolongation of PFS and response rate compared to chemo alone. Patients in the subgroup with EGFR L858R, without acquired T790M mutation, and presence of brain met showed more benefit. There was no difference in overall survival, though we need more mature data. Adverse events were higher in the ABCP arm. Interestingly, in the exploratory analysis, a high PD-L1 and an inflamed score of more than 20% showed PFS benefits. Though we need to take into consideration that this trial was done and all the patients were grouped from a single country considering Asian ethnicity. And most importantly, the majority of patients were treated with first- and second-generation TKIs, whereas third-generation TKIs are the standard of care in the United States. Coming to the Oncology Grand Round, in this case, we will discuss the management of treatment resistance in patients with advanced EGFR-mutated lung cancer. A patient with a 20-pack-a-year history of tobacco use presents with weight loss and hip pain, found to have a lung mass, skeletal mets, and brain mets, and was diagnosed with lung adenocarcinoma. The patient goes with palliative radiotherapy for the brain mets. Comprehensive tumor Merkel profiling demonstrated an EGFR mutation exon 19 and alteration P53. The patient was started on third-generation EGFR TKI osimertinib. However, after 17 months, the patient has symptomatic disease progression. Usual approach, if feasible, re-biopsy at the time of progression to evaluate for possible new mutations which can guide treatment options. As mentioned earlier, in the trial, acquired resistance to the TKI is inevitable and heterogeneous. There were various mechanisms which have been proposed regarding resistance, including a second-site EGFR alteration, upregulation of bypass pathway, histological transformation to small cell histology, or suboptimal drug penetration. There are various approaches after disease progression on EGFR TKI. Combining EGFR-directed therapies to address resistance is an option. Prime results from the MARIPOSA-2 study showed amivantamab plus chemotherapy with or without lazertinib in EGFR-mutated non-small cell lung cancer after disease progression showed a better objective response rate at 64% compared to 36% in the chemo-alone arm. It also showed improved PFS with a median of 6.3 compared to 4.2 in the chemo-alone arm. Combining immune checkpoint inhibitors, EGFR-mutated non-small cell lung, I say has been disappointing in advance of EGFR-mutated non-small cell lung, and combination therapy studies are needed to improve outcomes. Studies, as I discussed ATTLAS, have shown that combining a VEGF inhibitor with ICIs and chemotherapy can lead to a better objective response rate and PFS. However, further clinical trials are needed to figure out the better subgroup of patients who can benefit from this combination. Should the TKI be continued beyond progression in EGFR-mutated advanced non-small cell lung cancer? Continuing the primary EGFR TKI treatment beyond progression may be considered for patients with indolent or asymptomatic progression or localized progression. We can consider radiation, surgery, or ablation. This approach will potentially delay the need to change systemic therapy in patients. However, for patients with multifocal disease progression requiring chain systemic therapy it may be more beneficial to switch to next-line systemic therapy options like platinum doublet with or without immunotherapy and VEGF inhibitors. In the case presented, the decision was made to continue osimertinib along with platinum doublet, deferring the addition of immunotherapy and VEGF inhibitor. This choice was based on factors like the patient's history of brain metastases and intracranial control. There is also a high risk of toxicity, especially pneumonitis, with immune checkpoint inhibitors after using targeted therapy, the patient showed clinical and radiographic improvement while on this treatment regimen. The decision to continue or change therapy at cancer progression is based on factors like drug tolerability, patient preferences, and specific subgroups with different outcomes, such as those with brain metastasis or specific EGFR mutation subtypes. Choosing between combination therapy strategies that concept progression involves personalized decision-making to optimize treatment outcomes. Ultimately, the approach to management should be tailored to individual patient needs, preferences, and eligibility for different treatment modalities. This is Rohit Singh. Thank you for listening to JCO Article Insights. Don't forget to give us a rating or review and be sure to subscribe so you never miss an episode. You will find all the ASCO shows at asco.org/podcasts. Thank you. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions ofASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
The Community Emergency Response Team (CERT) program offers a consistent, nationwide approach to volunteer training and organization that professional responders can rely on during a disaster. On the FEMA Preparedness Community, you can search for a program, register your group, and stay connected in your neighborhood! Please tune in to our guest, Frances Whalen, NEMBA, ABCP, a CERT specialist, to learn about CERT!What we discuss:CERT Trainings, Portal, and CommunityFinding a local CERTAnnual CERT Conference Resources from this episode:FEMA CERT: https://community.fema.gov/PreparednessCommunity/s/welcome-to-cert? Get #Social: Substack Newsletter | https://iaemr9.substack.com/LinkedIn | https://www.linkedin.com/showcase/iaem-usa-region-9Twitter | https://twitter.com/iaemr9Facebook | https://www.facebook.com/IAEMR9Instagram | https://www.instagram.com/iaemr9/
PerfWeb 98 Day 3, offering an in-depth exploration into the critical role of imaging in the field of perfusion. Scheduled for Wednesday, March 20, 2024, this session promises to enrich participants with a comprehensive understanding of various imaging modalities and the skills to interpret these images effectively. Accredited with 2.4 Category 1 CEUs by the American Board of Cardiovascular Perfusion (ABCP), Day 3 is designed to elevate the proficiency of perfusionists in utilizing imaging for diagnostic, monitoring, and therapeutic purposes. Event Overview Date: Wednesday, March 20, 2024 Time: 1500-1700 The focus of Day 3 is twofold, beginning with a session on the diverse range of imaging modalities used in perfusion and followed by a detailed guide on interpreting these images. This day is essential for perfusionists looking to enhance their diagnostic acumen and apply imaging insights to improve patient outcomes. The sessions promise to be both informative and transformative, equipping attendees with the knowledge and skills necessary for excellence in perfusion practice. Session Details 1500-1600: Imaging, Imaging, Imaging: What Imaging Is Used For Faculty: V. Patel, MD The first hour, led by V. Patel, MD, will delve into the various imaging modalities utilized in the field of perfusion, such as CT scans, MRIs, X-rays, and ultrasounds. This session aims to elucidate the specific applications of each imaging technique, highlighting their roles in assessing cardiovascular structures, monitoring perfusion, and guiding therapeutic interventions. Attendees will gain a clear understanding of the strengths and limitations of each modality, enabling them to select the most appropriate imaging technique for different clinical scenarios. 1600-1700: How To Read Imaging Faculty: V. Patel, MD Continuing the educational journey, V. Patel, MD, will provide a detailed guide on interpreting medical images. This session is designed to equip perfusionists with the essential skills for analyzing imaging results accurately, understanding normal versus pathological findings, and integrating this information into their clinical decision-making processes. The presentation will cover key principles of image interpretation, common pitfalls to avoid, and practical tips for enhancing diagnostic accuracy. CEU Accreditation PerfWeb 98—Day 3 has been approved for 2.4 Category 1 CEUs by the ABCP, recognizing the high educational value and relevance of this session to the perfusion community. This accreditation highlights the commitment to providing quality education that supports the professional growth and development of perfusionists. Why Attend? Expert Guidance: Learn from an experienced medical professional specializing in imaging, enhancing your understanding of various imaging modalities and interpretation techniques. CEU Accreditation: Secure 2.4 Category 1 CEUs to meet your professional development requirements and maintain ABCP certification. Skill Enhancement: Improve your ability to select appropriate imaging techniques and interpret images accurately, leading to better patient care and outcomes. Professional Growth: Engage with the latest advancements in imaging technology and practices, staying at the forefront of the perfusion field. Registration and Participation Perfusionists interested in attending PerfWeb 98—Day 3 are encouraged to register in advance to secure their participation. Detailed registration information, including any fees, can be found on the event's official website. Attendees will also benefit from access to session recordings after the event, allowing for continued learning at their convenience. PerfWeb 98—Day 3 stands as an invaluable resource for perfusionists eager to master the use of imaging in their practice. By offering a deep dive into the applications and interpretation of medical images, this session aims to empower perfusionists with the skills needed to leverage imaging technology for enhanced clinical decision-making and patient care. Join us on March 20, 2024, for a day of insightful learning and professional development that promises to make a significant impact on the future of perfusion.
O que é Educação Midiática? E o que é Educomunicação? Como órgãos públicos podem atuar nesse campo? Que tipo de ação podemos desenvolver? Educação midiática pode ser um meio de combate às fake news? Como fazer isso no âmbito da comunicação digital? doutor em Ciências Humanas e Sociais, chefe dos Serviços de Comunicação Social da Câmara Municipal de Cubatão (SP) e diretor-adjunto da Regional São Paulo da ABCPública. Contato do Michel Carvalho: @michelcarvalhojor
PerfWeb 98 continues its educational journey into Day 2, focusing on the pivotal aspects of Extracorporeal Life Support (ECLS) and its adverse effects. Scheduled for Tuesday, March 19, 2024, this session is a crucial convergence for perfusionists, offering deep dives into the complexities and challenges associated with ECLS treatments. Endorsed with 1.2 Category 1 CEUs by the American Board of Cardiovascular Perfusion (ABCP), this seminar underscores the commitment to providing cutting-edge education and fostering a deeper understanding of critical care in perfusion practices. Event Overview Date: Tuesday, March 19, 2024 Time: 1700-1900 PerfWeb 98—Day 2 is singularly designed to enrich the knowledge base of perfusionists with a comprehensive exploration of ECLS. This session aims to equip professionals with the insights needed to navigate the adverse effects of ECLS, enhancing patient care and outcomes. The seminar is an essential platform for those in the field seeking to bolster their expertise, stay updated with the latest research, and engage in meaningful discussions on overcoming ECLS challenges. Session Details Adverse Effects of ECLS Faculty: V. Carlyle, RN, BSN-CCRN The session will be led by V. Carlyle, RN, BSN-CCRN, a distinguished figure in the field of critical care nursing with extensive experience in ECLS. Carlyle's presentation is set to cover the gamut of potential adverse effects associated with ECLS, including but not limited to thrombosis, bleeding, infection, and neurological complications. The session aims to not only outline these challenges but also to delve into preventive strategies, management techniques, and the latest research findings that can help mitigate these adverse effects. Participants will have the opportunity to engage in an interactive discussion, sharing experiences, strategies, and questions related to ECLS complications. This collaborative environment is designed to foster a community of learning and support among perfusionists and critical care professionals. CEU Accreditation This session has received the approval of 1.2 Category 1 CEUs by the ABCP, validating its educational merit and relevance to the perfusion community. This accreditation ensures that participants are recognized for their dedication to advancing their knowledge and skills, contributing to their professional development and the quality of care provided to patients. Why Attend? Expert Insights: Gain valuable knowledge from an experienced professional in the field of critical care and ECLS, enhancing your understanding of the adverse effects and management strategies. CEU Accreditation: Earn 1.2 Category 1 CEUs approved by the ABCP, supporting your professional development and maintaining your certification. Collaborative Learning: Benefit from the shared experiences and strategies of peers, enriching your practice and problem-solving skills. Critical Updates: Stay informed on the latest research and developments in ECLS, ensuring your practice is aligned with current standards and best practices. Registration and Participation Advance registration is encouraged for those planning to attend PerfWeb 98—Day 2. Complete details on how to register, including any associated fees, can be found on the official event website. Participants will also have access to post-event session recordings, offering flexibility in engaging with the material at their convenience. PerfWeb 98—Day 2 is an indispensable opportunity for perfusionists to deepen their understanding of ECLS, confront its adverse effects, and explore innovative solutions for enhancing patient outcomes. This seminar promises to be a valuable addition to the educational calendar of any perfusionist committed to excellence in their field. Join us on March 19, 2024, to partake in an educational experience that will shape the future of perfusion practices and patient care across North America.
PerfWeb 98 presents an educational milestone for perfusionists across the United States and Canada, offering an unparalleled opportunity to earn continuing education units (CEUs) while enhancing professional knowledge and skills. Scheduled for Monday, March 18, 2024, this event promises to be a pivotal gathering for professionals seeking to stay at the forefront of perfusion technology and medical advancements. PerfWeb 98—Day 1 is meticulously organized into two sessions, each focusing on critical areas of perfusion science and practice, accredited with 2.4 Category 1 CEUs by the American Board of Cardiovascular Perfusion (ABCP). This seminar is designed not just as a means to fulfill continuing education requirements but as a platform to foster discussions, encourage the exchange of ideas, and enhance the professional competency of perfusionists. The sessions are tailored to both seasoned professionals and those new to the field, providing insights into technological advancements and clinical applications. Session Details 1700-1800: Design of an EMR Perfusion Platform Faculty: T. DiSalvo, CCP The first session, led by the distinguished T. DiSalvo, CCP, focuses on the critical topic of Electronic Medical Records (EMR) in the realm of perfusion. This session aims to delve into the intricacies of designing a perfusion-specific EMR platform, addressing the unique needs and challenges faced by perfusionists in documenting and managing patient data. Participants will gain insights into the latest trends in EMR technology, best practices for EMR system design, and strategies for integrating these systems into their daily practice to improve patient care and operational efficiency. 1800-1900: How the Oxyhemoglobin Dissociation Curve Affects NIRS Faculty: T. DiSalvo, CCP Continuing the educational journey, T. DiSalvo, CCP, will lead the second session, exploring the significant impact of the oxyhemoglobin dissociation curve on Near-Infrared Spectroscopy (NIRS) measurements. This presentation aims to unravel the physiological and clinical implications of the oxyhemoglobin dissociation curve, providing perfusionists with a deeper understanding of how NIRS can be used to monitor and optimize patient oxygenation during cardiovascular surgeries. Attendees will engage in a comprehensive discussion on interpreting NIRS data, integrating physiological principles into clinical practice, and enhancing patient outcomes through informed decision-making. CEU Accreditation PerfWeb 98—Day 1 has been approved for 2.4 Category 1 CEUs by the ABCP, underscoring its educational value and relevance to the perfusion community. This accreditation affirms the quality and depth of the content presented, ensuring that participants receive recognition for their commitment to continuing education and professional development. Why Attend? Educational Excellence: Learn from seasoned professionals and thought leaders in the field of perfusion, gaining valuable insights and knowledge that can be directly applied to your practice. CEU Accreditation: Fulfill your continuing education requirements with sessions approved by the ABCP, ensuring your professional credentials remain current. Networking Opportunities: Connect with peers and experts within the perfusion community, fostering relationships that can support your professional growth and development. Cutting-Edge Topics: Stay ahead of the curve with discussions on the latest technological advancements and clinical practices in perfusion science. Registration and Participation In conclusion, PerfWeb 98—Day 1 represents a critical platform for perfusionists aiming to enhance their professional skills, stay abreast of the latest developments in the field, and meet their CEU requirements. Through engaging lectures, interactive discussions, and comprehensive educational content, this event promises to be an invaluable resource for the perfusion community. Join us on March 18, 2024, for an enriching experience dedicated to advancing the practice of perfusion across North America.
The ABC of ABG. Ph stat vs. Alpha stat ABG for Profound Hypothermia. Welcome to our upcoming webinar, a pivotal educational event tailored for perfusionists seeking to expand their knowledge and expertise in arterial blood gas (ABG) analysis and management during profound hypothermia. This webinar is part of our commitment to providing continuous education and valuable resources for perfusionists, enabling them to earn CEUs while enhancing their professional skills. Part 1: The ABC of ABG - Presented by J. Basha, CCP The first segment of our webinar, "The ABC of ABG," will be led by the esteemed J. Basha, CCP, a renowned expert in the field. This session aims to demystify the complexities of ABG analysis and provide a solid foundation for understanding its critical role in patient management. Understanding ABG: We begin with the basics, explaining the components of ABG, including pH, PaCO2, PaO2, HCO3-, and SaO2. This foundational knowledge is crucial for perfusionists to make informed decisions during cardiopulmonary bypass procedures. Clinical Relevance: The session will delve into the clinical significance of each component of ABG, illustrating how they directly impact patient outcomes. Real-world case studies will be used to demonstrate the practical application of ABG analysis in various clinical scenarios. Interpreting Results: A comprehensive guide on interpreting ABG results will be provided. This includes understanding acid-base balance, recognizing common disorders like acidosis and alkalosis, and applying this knowledge in clinical practice. Part 2: Ph Stat vs. Alpha Stat ABG for Profound Hypothermia - Presented by B. Bolkacav, CCP The second part of our webinar, led by B. Bolkacav, CCP, focuses on the critical decision-making process in managing ABG during profound hypothermia, a common scenario in cardiac surgeries. Ph Stat and Alpha Stat - A Comparative Overview: This session will offer an in-depth look at both Ph Stat and Alpha Stat strategies, discussing their principles, methodologies, and clinical implications. Impact on Perfusion Strategy during Hypothermia: The choice between Ph Stat and Alpha Stat management during profound hypothermia can significantly influence patient outcomes. We will explore how these strategies affect cerebral blood flow, oxygen delivery, and overall patient stability. Case Studies and Best Practices: Drawing from a wealth of experience, Bolkacav will present case studies highlighting the application of both strategies. This practical approach will help perfusionists understand the nuances and best practices for managing ABG during profound hypothermia. Interactive Q&A Sessions: Both sessions will conclude with a live Q&A segment, allowing participants to engage directly with our experts. This interactive component is designed to clarify doubts, discuss complex scenarios, and share experiences among peers. Why Attend This Webinar? Enhanced Knowledge: Gain an in-depth understanding of ABG analysis and its critical role in perfusion, along with specialized knowledge in managing ABG during profound hypothermia. Expert Insights: Learn from seasoned professionals who bring a wealth of experience and practical insights. Networking Opportunity: Connect with fellow perfusionists, fostering a community of learning and professional growth. Earn CEUs: This webinar is accredited by the ABCP, offering valuable CEUs to help meet your professional development requirements. Join Us: This webinar promises to be an enriching experience, combining theoretical knowledge with practical insights. It's an essential addition to the professional toolkit of every perfusionist who strives for excellence in patient care. We eagerly look forward to your participation in this enlightening and engaging session. Faculty: J. Basha, CCP B. Bolkacav, CCP
Seria possível otimizar recursos humanos e orçamentários por meio de uma nova divisão de trabalho das atividades de comunicação? No episódio de hoje, vamos conhecer duas experiências práticas de instituições nacionais que optaram por criar centrais de comunicação, deixando para trás o modelo regionalizado e geográfico. Quem conta como o novo modelo está funcionando é Dione Tiago, secretária de comunicação do Ministério Público Federal (MPF) e George Magalhães, chefe de relacionamento com a Imprensa da Empresa Brasileira de Serviços Hospitalares (Ebserh). Para conhecer a Portaria que regulamentou o Sinacom no MPF, acesse o Mapa de Regulamentação da ABCPública: https://abcpublica.org.br/wp-content/uploads/2023/08/PT_PGR_MPF_2023_407.pdf
Alec is one of the warmest, kindest, most wholesomely genuine & joyful humans on the internet, and he also happens to play (and teach) bagpipes! Tune into this episode to hear, how Bagpipe Yoga became the fitness sensation which is now sweeping the nation... - African Blackwood Conservation Project Fundraiser: Get Bagpipe Ready & BagpipeSwag have joined forces to create an eco-friendly fundraising T-shirt to benefit a charity in Tanzania which helps to conserve and re-forest the Dalbergia Melanoxylon (African Blackwood) tree. Check out the shirts at BagpipeSwag.com, and pick one up to help out the ABCP! (consider ordering a size-up, these eco-friendly Ts are a little on the tight side) Direct link to the shirts: https://www.bagpipeswag.com/get-bagpipe-ready Direct link to the African Blackwood Project: https://www.blackwoodconservation.org/ - APPLICABLE LINKS -Here's Alec's website: https://www.getbagpipeready.com/ -And their YouTube Chanel: https://www.youtube.com/channel/UCPG89uN_o4oQGjL8sUBBgPw (And Get Bagpipe Ready is all over the social media feeds, etc) - We're on Facebook: https://www.facebook.com/DroningOnPodcast And Instagram: https://www.instagram.com/droning.on.podcast/ - You can write-in to the show with comments, ideas, requests, etc. at TheDroningOnPodcast@gmail.com - Support the show via Patreon (patreon.com/DroningOnPodcast), or by buying cool stuff at BagpipeSWAG.com - - - And now, some keywords: Bagpipes, bagpipe, bag, pipe, pipes, pipe, band, pipeband, Scottish, small, drone, droning, chanter, highland, lowland, smallpipe, smallpipes
We're joined by credit analysts Dev Vithani, Joshua Saunders, and Maxime Pontois to discuss some of the alternative financing arrangements that are on an uptick in the asset-backed commercial paper (ABCP) sectors in U.S. and EMEA and how they support issuance growth. We also discuss the impact of the recent events in the banking sector on the U.S. and EMEA ABCP markets. And finally, we go into our expectations for global issuance totals for this year.
O que faz (ou deveria fazer) um comunicador público? Quais os maiores desafios da função? Será que compreendemos a importância e o potencial do nosso trabalho? Existe uma formação ideal para atuar com comunicação pública? Que competências precisamos ter ou desenvolver? Como é o ingresso na carreira? E as formas de contratação? E como será o comunicador público do futuro? Esse episódio foi produzido com trechos das falas das palestrantes do Seminário Papel e Carreira do Comunicador Público, realizado pela ABCPública em novembro de 2022. Para assistir à íntegra do evento, acesse: https://www.youtube.com/watch?v=fyBgtRZqjxA&t=5567s
경제자유살롱 뭘스트리트
WELCOME TO THE BEAUTY OF BREATHING PODCAST! Join Dr. Martha Cortes and Dr. Jennifer Hobson, the dynamic Dental & Physical Therapist Duo to learn how treating the airway, and proper breathing and swallowing will restore the body to health. In this episode, Dr. Jennifer Hobson and Dr. Martha Cortes will be interviewing Dr. David Shirazi DDS, MS, MA, L.Ac., D.ABCP, D.ABC-DSM TOPICS OF DISCUSSION Why do we clench and grind our teeth? What are the different appliances used to help craniofacial pain patients? What is the Advanced Light Wire Functional Appliance (ALF) and what are its uses? How to evaluate treat Temporomandibular joint disorder and Airway/breathing disorders? Neurological testing, Motor reflex testing which tells you what structure is in sympathetic dystrophy and the origin. What is Dr. Shirazi's tip on how to be the healthiest “you” possible. ______________________________________ ABOUT OUR GUEST In 2000, Dr. Dave Shirazi rang in the new millennium by graduating from Howard University College of Dentistry, in Washington D.C. He went on to earn a Masters degree in Oriental Medicine from SAMRA University in 2006. In 2007 he received the prestigious Fellowship Award from the American Academy of Craniofacial Pain, an organization dedicated in the diagnosis and treatment of Craniofacial pain and Sleep Breathing Disorders. Dr. Shirazi has completed over 2000 hours of continuing education in MD and facial pain, craniomandibular orthopedics, and sleep disordered breathing. He lectures on those very subjects himself throughout the United States. Additionally, he fulfilled a hospital mini-residency in oriental medicine at the China Beijing International Acupuncture Training Center, the only institution authorized to teach globally on acupuncture and herbology by the World Health Organization. For more on Dr. Shirazi, visit: tmjandsleeptherapycentre.com. ______________________________________ ABOUT OUR HOSTS Dr. Martha Cortés, DDS is a general, cosmetic, biological, neuromuscular and laser dentist who sub-specializes in the treatment of sleep breathing disorders, and temporomandibular joint dysfunction (TMD). Her methods include non-surgical techniques to treat TMD, as well as, facial-airway-enhancement remodeling techniques designed to treat sleep apnea. Dr. Jennifer Hobson is a head and neck, TMJ physical therapist, protege of renowned expert, Dr. Mariano Rocabado. She is known for her treatment of TMJ, sleep disordered breathing, chronic headaches, concussion, neck pain, tinnitus, and postural dysfunctions. Dr. Hobson is trained in myofunctional therapy and is certified in the Buteyko Breathing Method. For more on Dr. Hobson and the Hobson Breathing Institute, visit: https://insights.hobsoninstitute.com/links.html Please, let us know how much you enjoy the show by leaving us a review! ______________________________________ At Airway Circle we offer a safe and supportive space for like-minded professionals to connect, collaborate and share information regarding airway-related issues and whole-body health. Our website: https://airwaycircle.com/
1. '타다' 2심서도 무죄 2. '레고랜드' ABCP(자산유동화 기업어음) 비상, 개인 투자자 손실 우려 3. '한은' 사상 처음 외환보유액 백브리핑 나서 출연: 안승찬 기자, 김현우 소장, 박세훈 작가
A fireside chat with Ann Guercio, CCP, LP, MBA, and President of the ABCP.
O avanço de uma agenda igualitária de direitos relacionados a gênero tem um sentido claramente democrático. Por isso mesmo, a reação ultraconservadora a ela representa mais uma faceta da recessão democrática que marca nosso tempo. Essa agenda democratizante tem diversas dimensões: direitos reprodutivos, casamento igualitário, valorização da diversidade, educação voltada para a tolerância. Pois a reação a essa democratização ataca cada um desses pilares, denunciando uma suposta "ideologia de gênero". No âmbito internacional, um marco desse processo de afirmação de direitos foi a "IV Conferência Mundial sobre a Mulher: Igualdade, Desenvolvimento e Paz" das Nações Unidas. A ele se seguiram outros avanços no âmbito de organismos transnacionais. Não à toa o reacionarismo contemporâneo vê nos órgãos multilaterais um inimigo "globalista", que faz avançar o "marxismo cultural", em que a questão de gênero ocupa papel central. Mas afinal de contas, qual o sentido dessa democratização? E qual o significado dessa reação? Para discutir esses temas, este #ForadaPolíticaNãoháSalvação recebe a cientista política Flávia Biroli, professora da Universidade de Brasília, ex-presidenta da Associação Brasileira de Ciência Política (ABCP) e uma das principais referências brasileiras dos estudos de gênero. Twitter de Flávia Biroli: @FlaviaBiroli Músicas deste episódio: "Dakar Flow" e "Love in México", de Carmen María & Edu Espinal. Leia o blog do #ForadaPolíticaNãoháSalvação no site da CartaCapital. Agradecemos aos novo apoiadores do Fora da Política Não há Salvação: Solange Monteiro, Fernanda Loschiavo Noni e Maurício Borges Silva. Apoie o e ajude o canal e o podcast a se manterem e a melhorar! Apoiadores contarão com agradecimentos nos créditos dos episódios (claro, desde que desejem) e terão acesso a brindes digitais relacionados ao tema do canal: a política. Há três formas possíveis de apoio. Tornando-se membro do canal no Clube dos Canais do YouTube: https://www.youtube.com/channel/UCbSOn9WtyJubqodDk_nL1aw/join Tornando-se assinante do #FPNS no Benfeitoria. com: https://benfeitoria.com/projeto/ApoioForadaPoliticaNaohaSalvacao Por meio de PIX. Chave PIX: contato@foradapoliticanaohasalvacao.info #Gênero #LGBTQIA+ #DireitosdeGênero #Democracia #Sexualidade #IdeologiadeGênero #Conservadorismo #PânicoMoral #DireitosHumanos #ONU #Feminismo --- Send in a voice message: https://anchor.fm/fpns/message
Ann Guercio, CCP, President of the ABCP will discuss the future of the American Board of Cardiovascular Perfusion.
Quem trabalha com comunicação não pode parar nunca de se atualizar, não é? Reuni nessa pílula algumas dicas de cursos e eventos do mundo da comunicação que podem interessar aos ouvintes :) Os cursos que citei foram: - Programa Avançado de Comunicação Pública - ABCPública e Aberje - www.abcpublica.org.br/pacp - Pós-graduação online em Comunicação Pública e Governamental da PUC-MG - https://bit.ly/3LlcUnM - Evento Redes WeGov - maio - Florianópolis-SC - www.wegov.com.br - Conbrascom - Congresso Brasileiro de Comunicação do Sistema de Justiça - agosto - Rio de Janeiro-RJ - www.fncj.org.br - Conexthon 5.0 - Maratona de inovação para instituições públicas - https://linktr.ee/conexinovapub - Curso sobre Linguagem Simples - Enap - Curso sobre Cultura Organizacional - Casper Líbero - Curso sobre comunicação digital - Agência Koko - @agenciakoko - Curso sobre mensuração de resultados para órgãos públicos - Daniela Senador - https://www.danisenador.com - Curso Escrita Criativa e Afetuosa - Ana Holanda - Curso O caminho da comunicação autêntica - Carolina Nalon - https://institutotie.com.br ->>> Para cursos comigo (Aline Castro): alinecastrosilv@gmail.com ou @alinecastrocomunica
Não, não vai ser um ano fácil. Pandemia, eleições, desinformação, polarização social e um mundo de coisas nas nossas listas de tarefas. Como nós comunicadores públicos devemos atuar em 2022? O que priorizar? Como lidar com os novos e velhos desafios? Nesse episódio, Ana Cristina Rosa, assessora-chefe de comunicação do Conselho da Justiça Federal (CJF) e coordenadora regional da ABCPública no DF, fala sobre a sua experiência e dá dicas para sobrevivermos a 2022. Nosso papo foi uma delícia e ela abordou temas como comunicação digital, interação, relacionamento com a imprensa e muito mais.
Jatin Sapru has been a familiar face for cricket lovers on Star Sports. ABCP chats with 'The Cricket Guy' (Jatin Sapru) about, dropping out off Engineering and heading towards broadcasting, having no idea of where he would land, eventually had to be cricket. He opens out on his family struggles in the early 90's. His memories of hosting his first live event with Sanath Jayasuriya, stories of The Cricket Junkie, Gautam Bhimani, the unknown side of Virat Kohli, having fun in the studio, with Irfan Pathan. Is it difficult to make Gautam Gambhir smile? How does he manage jetlag? Join us on Discord to get a chance to chat with us: https://discord.gg/A8fvRtEV Support our show: https://buymeacoffee.com/atombiggcricpod You can follow Atom Bigg Cricket Podcast on Social Media. Instagram: https://instagram.com/atombigg_cricket Twitter: https://twitter.com/atombigg_cric Like us on Facebook:https://m.facebook.com/atombiggcricket/ YouTube: https://youtube.com/channel/UC5_97eO_twui2UF6ksDmajA --- Send in a voice message: https://anchor.fm/atombigg-cricket/message
Em guerra contra os outros Poderes – em especial o Judiciário –, governos subnacionais e imprensa, Jair Bolsonaro convoca inflamadamente seus apoiadores para um 7 de Setembro Fascista. O propósito dos atos, para os quais uma imensa e intensa mobilização se produziu nas hostes bolsonaristas, é atacar os limites democráticos ao exercício do poder autocrático pelo presidente da República. Bolsonaro não aceita quaisquer limites ou contrariedades que possam, legitimamente, ser-lhe impostos pelo Judiciário, pelo Legislativo, pelos governos subnacionais ou pela imprensa independente. Não à toa, anunciou a seus apoiadores que o 7 de Setembro Fascista será um "ultimato" aos ministros do STF que ousam lhe contrariar – Luís Roberto Barroso e Alexandre de Moraes. Não bastasse, Bolsonaro também tem insistido na participação de membros das forças de segurança, em especial as polícias, nas manifestações antidemocráticas marcadas para o dia da Independência. Que riscos efetivamente isso representa para a democracia? Para discutir esse tema, a convidada deste #ForadaPolíticaNãoháSalvação é a cientista politica Maria Hermínia Tavares de Almeida, professora aposentada da USP, onde também criou o Instituto de Relações Internacionais (IRI). Maria Hermínia foi presidente da Associação Brasileira de Ciência Política (ABCP) e da Latin American Studies Association (LASA) e é pesquisadora do CEBRAP. As músicas deste episódio são "Dragon and Toast" de Kevin MacLeod e "Horses to Water" de Topher Mohr & Alex Elena. Leia o blog do #FPNS na CartaCapital. #Democracia #Autoritarismo #Bolsonarismo #GovernoBolsonaro #Golpismo #ExtremaDireita --- Send in a voice message: https://anchor.fm/fpns/message
ABCP is in conversation with Kartik Murali, classical left arm spinner and who possessed all the weapons in his armory. He has played 37 ODI's, 8 Test matches and 1 T20I for the Indian Cricket Team. He has also been part of the RCB franchise in the IPL. He, now is an articulate commentator. His voice is crisp and people love to hear him. We talk about Ind v Eng - England beat India at Leeds (3rd Test) - 78 all out! Was it India's poor batting? Or was it England's terrific bowling? - How extraordinary has Ollie Robinson been? - How to stop watching, Joe Root score
Em pouco tempo, muitas incertezas foram produzidas sobre as eleições de 2022. Numa mesma semana discutiu-se e decidiu-se na Câmara sobre voto impresso ou não, sistema eleitoral para a Câmara de Deputados, coligações em eleições proporcionais e federação de partidos. Agora, cabe ao Senado a palavra final sobre algumas dessas questões, notadamente as coligações proporcionais e outros aspectos das regras eleitorais e partidárias. Este #ForadaPolíticaNãoháSalvação discute esse assunto. Para isso foram convidados os cientistas políticos Luciana Veiga, presidente da Associação Brasileira de Ciência Política (ABCP) e professora da Unirio; e Vitor Marchetti, professor da UFABC. A música deste episódio é Oh, Fire! De Carmen María & Edu Spinal. Leia nosso blog na CartaCapital! #Eleições #Sistema Eleitoral #Distritão #Coligações --- Send in a voice message: https://anchor.fm/fpns/message
On todays episode we speak with SSG Holbrock about The Army Body Composition Program (ABCP) and how it effects the mental health of soldiers who cannot meet the standard based on body shape.Soldiers are subject to many demands and challenges that may impact individual readiness. The ABCP provides com- manders a systematic approach to enforce military standards across the unit, while supporting Soldiers with the resources they need to return to an optimum level of individual readiness. Does it?-SponsorshipI'm sure you've heard that Alcohol Use Disorder, addiction and mental health issues in general are on the rise, especially during the pandemic.That's why Brainwashed Coffee Co works to raise money and awareness to support people seeking help. By donating 50% of profits, their mission is to give back to the amazing recovery community. Their "why" is bold and their coffee is fresh! So, if you want to sip an amazing brew that warms your mind, body and soul then visit Brainwashedcoffeeco.com and use code EXTRADUTY at checkout for 20% off your coffee order. Brainwashed Coffee Co. Simple coffee for complicated people link in the bio!!Extra Dutylisten to the episode on YouTube: we are available onApple PodcastBreakerGoogle PodcastPocket CastRadio PublicSpotifyYouTube-- You guys can use our Link tree to get to all of our socialshttps://linktr.ee/Extraduty-- contact uș directly at extradutypodcast@gmail.comAlways do a buddy check!!Buddy Check numbers800-273-8255 - Suicide HotlineGermany 08001810771Belgium 02 648 40 14Italy 800860022Poland 5270000Korea 080-8555-118800-931-2237 - Eating Disorder Hotline800-656-4673 - National Assault Hotline800-222-1222 - Poison Control Hotline800-799-7233 - National Domestic Violence Hotline877-565-8860 - Transgender Suicide Hotline202-498-4009 - SHARP Crisis LineText 838255 (Veterans Crisis Hotline)Text HOME to 741741Or you can download the WeCare app for contact and resources. other resources:https://www.militaryonesource.milhttps://www.ptsd.va.gov/understand/awareness/ptsd_treatment_works.asp?utm_source=Google&utm_medium=GS3YM&utm_campaign=NCPTSDhttps://www.mentalhealth.gov/get-help/veterans--- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app--- Send in a voice message: https://anchor.fm/joushua-maria7/messageSupport this podcast: https://anchor.fm/joushua-maria7/support
Con la expansión global del coronavirus, muchos gobiernos de la región latinoamericana han tenido que lidiar con muchos desafíos. Además de la complejidad biológica del virus, se requiere conseguir un patrón comunicacional claro que preserve la salud pública, al tiempo de permitir de forma segura la productividad de cada país. Y es precísamente en este ámbito, donde se juega en buena medida el éxito o fracaso de esta gestión sanitaria. Contexto especialmente desafiante entre liderazgos populistas, adictos a las medidas de corto plazo, a las soluciones de fe y a los peligrosos excesos de confianza. Tal como ha sido la comunicación política en Brasil y su impacto en los efectos de la pandemia. Después de más de un año de la llegada de la COVID-19, su Presidente Jair Bolsonaro ha desafiado en innumerables ocasiones la viralidad y mortalidad del virus, así como también con sus declaraciones y acciones ha puesto en riesgo la integridad de las instituciones federales, obstaculizando el diálogo permanente necesario entre los distintos sectores de la sociedad en la promoción de soluciones oportunas. Los datos dan cuenta de este manejo errático de la pandemia. De acuerdo a las cifras oficiales, Brasil es el segundo país latinoamericano con la mayor cantidad de muertos por cada 100.000 habitantes, solamente superado por el Perú. La entrevistada Para evaluar en profundidad este panorama, contamos con el análisis de la profesora Luciana Veiga. Politóloga y profesora de la Universidad Federal del Estado de Río de Janeiro (UNIRIO). Doctora en Ciencia Política por IUPERJ (atual IESP/UERJ). Presidente además de la Asociación Brasileña de Ciencia Política (ABCP). Con su aporte, profundizamos sobre el mensaje institucional, sus contradicciones y sus impactos en la gestión sanitaria. Así como también, cómo los resultados de este manejo errático, pudieran erosionar el capital político de Jair Bolsonaro de cara al año electoral del 2022. La gestión pública en general enfrenta tensiones extraordinarias, dificultades de acceso a las vacunas, muchas incertidumbres sobre la reactivación comercial y una complejidad que pocos gobiernos deciden reconocer y comunicar con responsabilidad a su ciudadanía. Lo cual demanda de mayores niveles de coordinación, interlocución y evaluación profesional de los riesgos, más que de actos de fe, mandatos ideológicos, silencios forzados y supresión a cualquier foco de crítica. En suma, es necesario un gobierno más cognitivo y dispuesto a aprender, que trate a sus ciudadanos como personas adultas y no como una agregación de feligreses con el único deber de creer irreflexivamente en el líder. Tal como lamentablemente ha ocurrido en el Brasil del último año. Conoce nuestros artículos visitando nuestra página web, así como también suscríbete a nuestro Newsletter para que estés al tanto de los que semanalmente publicamos y con ello ser parte de nuestra creciente comunidad
Tudo indica que teremos mais um ano repleto de desafios. Da desinformação desenfreada aos novos hábitos de consumo, passando pelo trabalho remoto: como fazer comunicação pública no meio de tudo isso? Que escolhas podemos fazer e que mídias devemos priorizar? Embasada por diversos estudos internacionais, a nossa entrevistada da vez, Claudia Lemos, traz 7 dicas de tendências para o ano de 2021. Claudia é jornalista na Câmara dos Deputados e presidente da ABCPública. Se você quer sugerir algum tema ou entrevistado para o nosso podcast, fale comigo lá no Instagram: @alinecastrocomunica. #comunicacaopublica #comunicacao #tendencias
Faz seis meses da confirmação dos primeiros casos de covid-19 no Brasil. É nítido enxergar o papel absolutamente fundamental que a mídia e a comunicação pública tiveram nesse período inédito e histórico da humanidade. Mas quais foram nossos principais acertos? E o que poderia ter sido melhor? Nesse episódio você ouve os melhores momentos da live promovida pela ABCPública no YouTube no dia 26 de agosto. Com Wanderson Oliveira - epidemiologista e ex-secretário de vigilância do Ministério da Saúde Deputado Luiz Antonio Jr - presidente da Comissão de Enfrentamento à Covid-19 Cleber Mata - secretário de comunicação do Governo de São Paulo Alisson Bacelar - coordenador de comunicação do Governo do Piauí Lincoln Macário - jornalista a TV Câmara e presidente da ABCPública
H. Jack West, MD, joins the podcast to discuss the latest trials of immunotherapies in the treatment of lung cancer. Dr. West is an associate clinical professor in medical oncology at City of Hope Comprehensive Cancer Center in Duarte, Calif., and a thought leader in thoracic oncology. Dr. West and Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, review Keynote-042, Keynote-189, and IMpower150, and discuss how the findings influence practice. You can find Dr. West on Twitter at @JackWestMD. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, discusses how to be nonjudgmental when talking to patients about how they got cancer. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * This Week in Oncology: FDA Approves Ziextenzo for neutropenia-related infection reduction The FDA has approved the biosimilar Ziextenzo to reduce the incidence of infection in patients with nonmyeloid cancer who are receiving suppressive anticancer drugs that are associated with febrile neutropenia. Treatment for metastatic nonsquamous non–small cell lung cancer (NSCLC) without EGFR mutation or ALK translocation: Keynote-042 Design: Pembrolizumab alone vs. chemotherapy alone (carboplatin plus paclitaxel or carboplatin plus pemetrexed) 902 patients 1:1 randomization All patients with at least 1% PDL1 positivity Stratified into three groups: greater than 1%, greater than 20%, and greater than 50% PDL1 score No crossover permitted between groups Results: Overall survival is 16.7 months with pembrolizumab vs. 12.1 months with chemotherapy. PDL1 score 1% or greater: 16.7 months for pembrolizumab vs. 12.1 months for chemotherapy alone. PDL1 score 20% or greater: 17.7 months for pembrolizumab vs. 13.0 months for chemotherapy alone. PDL1 score 50% or greater: 20.0 months for pembrolizumab vs. 12.2 months for chemotherapy alone. There was no statistically significant difference in progression-free survival. Conclusion: Pembrolizumab monotherapy can be extended as first-line therapy to patients with locally advanced or metastatic non–small cell lung cancer and a high PDL1 score. Pembrolizumab monotherapy alone may not be the best choice for patients with a low PLD1 score. Keynote-189 Design: Pembrolizumab plus chemotherapy vs. placebo plus chemotherapy (pemetrexed plus platinum agent) 616 patients 2:1 randomization All patients with at least 1% PDL1 positivity Crossover to pembrolizumab monotherapy was permitted among the patients in the placebo-combination group who had verified disease progression Results: Overall survival to 12 months: 69.2% with pembrolizumab plus chemotherapy vs. 49.4% with chemotherapy alone. Progression-free survival: 8.8 months with pembrolizumab plus chemotherapy vs. 4.9 months with chemotherapy alone. Conclusion: Pembrolizumab should be added to standard chemotherapy of pemetrexed and a platinum-based drug for significantly longer overall survival and progression-free survival than chemotherapy alone, regardless of level of PDL1 positivity. IMpower150 Design: Atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) vs. bevacizumab plus carboplatin plus paclitaxel (BCP) vs. atezolizumab plus carboplatin plus paclitaxel (ACP) 1,202 patients 1:1:1 randomization Patients with any PD-L1 immunohistochemistry status were eligible Stratified by level of Teff gene-signature expression Results: Overall survival was longer in the ABCP group than in the BCP group (19.2 months vs. 14.7 months). Progression-free survival was longer in the ABCP group than in the BCP group (8.3 months vs. 6.8 months). In the Teff-high population, progression-free survival was significantly longer in the ABCP group than in the BCP group (11.3 months vs. 6.8 months). Conclusion: Addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NSCLC, regardless of PD-L1 expression. Unclear if ABCP regimen is superior to pembrolizumab monotherapy (in greater than 50% PDL1 group) or pembrolizumab plus pemetrexed plus platinum agent (in all PDL1 groups) as a four-drug regimen may be less attractive than these options. Teff status has not yet been proven to be useful for clinical decision making. References Mok TSK et al. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non–small cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial. Lancet. 2019;393:1819-30. Gandhi L et al. Pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer. N Engl J Med. 2018;378:2078-92. Socinski MA et al. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Engl J Med. 2018;378:2288-301. Show notes by Sugandha Landy, MD, resident in the department of internal medicine, University of Pennsylvania, Philadelphia. For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgehemonc Ilana Yurkiewicz on Twitter: @ilanayurkiewicz
1. "45년" 2. -한국경제TV 김치형 기자 3. "통계청 물가상승률은 실제 외식비, 생활비 상승률보다 낮나요?" 4. "중국 ABCP부실사태, 관련 펀드 환매해야하나?" -행복자산관리연구소 김현우 소장
Oh hiiiiiiiiiiii. Sorry, we've been locked out of the house for the past two years, nine months and 12 days, it was incredibly inconvenient, the cats are pissed. The point is, since the last episode of Awesomed By Comics, we've had another kid, moved, had a combined four jobs and blah blah blah you don't care. The point is, we got away this weekend and bought some comics and recorded an episode to talk about those comics, some of which are new this (last) week, some of which are not, all of which confused us because what is even going on in comics. We don't know when this will happen again, so join us as we struggle through. MISSED U BBs.
This paper analyzes the effect of the removal of government guarantees on bank risk taking. We exploit the removal of guarantees for German Landesbanken which results in lower credit ratings, higher funding costs, and a loss in franchise value. This removal was announced in 2001, but Landesbanken were allowed to issue guaranteed bonds until 2005. We find that Landesbanken lend to riskier borrowers after 2001. This effect is most pronounced for Landesbanken with the highest expected decrease in franchise value. Landesbanken also significantly increased their off-balance sheet exposure to the global ABCP market. Our results provide implications for the debate on how to remove guarantees.
Happy New Year! In this episode of Awesomed By Comics, we talk about some books we missed, wonder what happened to events, and look back on--what? Why are you looking at us like that? Why is that vein popping out of your forehead, are you having a--wait why are you screaming STOP SCREAMING! WE'RE SORRY, WE'RE SORRY OKAY?!? WE'VE BEEN BUSY! WE STILL LOVE YOU! WE'LL CHANGE, WE PROMISE WE'LL CHANGE!! So yeah, after nine months of three job changes each, two coasts, lots of stress eating and zero podcasts, we bring you a brand-spanking-new episode of Awesomed By Comics to kick off 2014. It's not a Year In Review show because we had very little year to review, and it's not a Week In Review show because we talk about comics over several weeks, but it is a real show and we did put in effort so we hope you'll give us another chance. Our New Years Resolution is to do this at least once a month, so we're counting on you to HOLD OUR ASSES ACCOUNTABLE. Special thank you to guest star , and to each and every one of you who bothers to listen. LET'S GO 2014! USA! USA!
This episode of Awesomed By Comics is not to be confused with Episode #170, which was fully recorded and edited (on Oscar Night no less), but then infected with a technovirus and now lives in its own pocket universe where you can hear it if you listen extremely closely during the 187th minute of R.E.M. (the sleep, not the band). We're actually at a place where we're giving awards to the current week's comics, although it may or may not be the same current week when this is actually released, you'll never know. Thanks for hangin in, partners.
Yearly Awards for what we thought this weekend was the best of the last year! Turns out we only did 10 shows last year. We're shooting for at least a 50% increase this year. There's a TON of stuff we didn't get to read - so tell us what your favorites were! What did the fish say to the other fish in the fish place? Something smells fishy to me!
The speaker will offer a glimpse behind the curtains, into the world of your investments as well as public money entrusted to governments, pension funds and institutions. We will hear how millions of dollars can be diverted from your pockets and your governments, into the hands of others and how self regulation can lead to decriminalization. Do investment regulators work for the public, or against? What about the police? Your Government? The speaker will look at conditions that come together to allow perfect financial crimes to occur with you as the unknowing victim. Are you as safe in Canada as you are told? Is there an intentional focus on criminal enforcement for the poor and the middle class, while deliberately ignoring crimes of the rich? What if your governments were aiding the criminally rich and privileged, by focusing 99.9% of crime effort on the rest? Are there any provisions in the recent Omnibus Crime Bill dealing with financial and White Collar crime? Speaker: Larry Elford, retired CFP, CIM, FCSI, Associate Portfolio Manager Larry worked inside the largest financial institutions in Canada for twenty years until his retirement in 2004. He works today writing, speaking and coaching Canadians on how to create safe and honest treatment for investors. He produced a documentary film to benefit investors, legislators and those who investigate financial crime. Larry is the founder and executive director of a web forum dedicated to revealing predatory practices and has appeared in two CTV W5 investigative reports on investment malpractice. He has also participated on CBC news programs, and as a witness in Ottawa to the Standing Committee on Finance on the ABCP sub prime mortgage crisis, April 10, 2008, and the Standing Committee On Justice and Human Rights hearings on Enhanced Criminal Charges for Financial Fraud, (Bill C52, C21) December 9, 2009.
The speaker will offer a glimpse behind the curtains, into the world of your investments as well as public money entrusted to governments, pension funds and institutions. We will hear how millions of dollars can be diverted from your pockets and your governments, into the hands of others and how self regulation can lead to decriminalization. Do investment regulators work for the public, or against? What about the police? Your Government? The speaker will look at conditions that come together to allow perfect financial crimes to occur with you as the unknowing victim. Are you as safe in Canada as you are told? Is there an intentional focus on criminal enforcement for the poor and the middle class, while deliberately ignoring crimes of the rich? What if your governments were aiding the criminally rich and privileged, by focusing 99.9% of crime effort on the rest? Are there any provisions in the recent Omnibus Crime Bill dealing with financial and White Collar crime? Speaker: Larry Elford, retired CFP, CIM, FCSI, Associate Portfolio Manager Larry worked inside the largest financial institutions in Canada for twenty years until his retirement in 2004. He works today writing, speaking and coaching Canadians on how to create safe and honest treatment for investors. He produced a documentary film to benefit investors, legislators and those who investigate financial crime. Larry is the founder and executive director of a web forum dedicated to revealing predatory practices and has appeared in two CTV W5 investigative reports on investment malpractice. He has also participated on CBC news programs, and as a witness in Ottawa to the Standing Committee on Finance on the ABCP sub prime mortgage crisis, April 10, 2008, and the Standing Committee On Justice and Human Rights hearings on Enhanced Criminal Charges for Financial Fraud, (Bill C52, C21) December 9, 2009.
The speaker will offer a glimpse behind the curtains, into the world of your investments as well as public money entrusted to governments, pension funds and institutions. We will hear how millions of dollars can be diverted from your pockets and your governments, into the hands of others and how self regulation can lead to decriminalization. Do investment regulators work for the public, or against? What about the police? Your Government? The speaker will look at conditions that come together to allow perfect financial crimes to occur with you as the unknowing victim. Are you as safe in Canada as you are told? Is there an intentional focus on criminal enforcement for the poor and the middle class, while deliberately ignoring crimes of the rich? What if your governments were aiding the criminally rich and privileged, by focusing 99.9% of crime effort on the rest? Are there any provisions in the recent Omnibus Crime Bill dealing with financial and White Collar crime? Speaker: Larry Elford, retired CFP, CIM, FCSI, Associate Portfolio Manager Larry worked inside the largest financial institutions in Canada for twenty years until his retirement in 2004. He works today writing, speaking and coaching Canadians on how to create safe and honest treatment for investors. He produced a documentary film to benefit investors, legislators and those who investigate financial crime. Larry is the founder and executive director of a web forum dedicated to revealing predatory practices and has appeared in two CTV W5 investigative reports on investment malpractice. He has also participated on CBC news programs, and as a witness in Ottawa to the Standing Committee on Finance on the ABCP sub prime mortgage crisis, April 10, 2008, and the Standing Committee On Justice and Human Rights hearings on Enhanced Criminal Charges for Financial Fraud, (Bill C52, C21) December 9, 2009.
This episode of the Awesomed By Comics Podcast is brought to you by the hurricane that we pretty much slept right through, and which did not give us an opportunity to bond while "hunkering down" but which was also far less destructive than it could have been which in the long run is a better thing for everyone. Winny wins this week for Mystery Men, Gotham City Sirens, Space Wolverines, Punishers, Captains America and Buckies and Confusingly-numbered Iron Man minis. We bid a fond farewell to this confusing iteration of Wonder Woman, and lament that the last-ever appearance of Oracle was as a side character in a hack-ass book. Plus Dr Who, Zelda, Vs. System, Pokemon Board Games, Iron Man Armored Adventures, The Origin of Stan, AND MANY MORE! The 150th is nigh! Be aware of street preachers and disco remixes! As always, leave your comments or picks on and if you like the show.
As we creep closer to our 150th show, this episode is brought to you by the return of the Zen Koan .... which quickly devolves into rap videos and masturbation jokes. Many loves for Daredevil, All Nighter, Journey Into Mystery, The Stuff of Legend, Generation Hope, and Power Girl. Not many loves for talksploitation comics and the death of fun. Many shenanigans including several trips to the MyTube, followed by FriendFace and BookSpace. Also we need a damn window in our studio. Or at the very least, a donkey with a box fan attached to it who can mill about the house spreading its cool donkey breeze. As always, leave your comments or picks on and if you like the show.
Whoa Nelly! This 147th episode of the Awesomed By Comics Website is brought to you by a little speed lesson! You got a need for speed? Then let's rev it up! Speed-style! VROOM VROOM VROOOOOOOOM. This week we bid a melancholy and vaguely disappointing farewell to Batgirl, which has been one of the entire industry's most solid titles, month-after-month, for the last two years, and whose lead character is not going to be appearing in the relaunch stuff for a while anyway. We also bid a lousy farewell to this incarnation of Birds of Prey, who deserved better than the sendoff they got. As Thor might apparently say, "Weak sauce, brah. Totes weak sauce." The Unwritten takes an interesting turn, and might be setting itself up for a pretty ballsy move, while Cloak and Dagger make a relationship book work in the midst of an event tie-in. Plus Squrlgurl. As always, leave your comments or picks on and if you like the show!
This extra-long episode of the Awesomed By Comics is brought to you by us soliciting ideas for our (now just four episodes away!!) 150th anniversary! That's right, Awesomed By Comics has been around for 150 years, 1874-2011!! Yes it does. Several of those years count as two or even three, if the crops were particularly bountiful. Anyway, this week renewed a lot of our faith in comics. Strong debuts for Rachel Rising, Severed, The Punisher, The Cape, Snarked and oh yeah, a certain new Ultimate hero. Strong endings for Secret Six and that thing about tennis which was silly but we loved it anyway. Plus great weeks for Irredeemable, Sweet Tooth, Thunderbolts, Hulk - MAN what a good week for comics. Also we talk about Iron Man Armored Adventures Season Two, which is off to a great start, and the next-to-last step for my band's next record which I've been working on and talking about for seriously at least two years. As always, leave your comments or picks on and if you like the show!
Hey! You know what? This episode of the Awesomed By Comics Podcast is brought to you by Horse Quotes, which we invite you to send in at your earliest convenience. We talk a little bit about the last couple weeks of books, recap the best and not-so-best of what we saw at SDCC, AND do our usual show about this week's books! It's like getting one and a quarter shows for the price of having to wait an extra two weeks! Which is not a very good deal at all! Venom, Gotham City Sirens, and Ultimate Fallout were all standouts this week, as were the first Ultimate Fallout and the debut of the all-new, all-not-miserable-anymore Daredevil. Meanwhile, an Eevee family was adorable and Dan DiDio was a colossal jackass at SDCC, but it appears DC is at least going to make an effort to address some of the concerns raised during its panels. (although we learned that too late to talk about it on the show.) Plus other stuff which I forget what it was because we recorded this a thousand days and three billion time zones ago. As always, leave your comments or picks on and if you like the show!
This episode of the Awesomed By Comics Podcast is brought to you by , which you can (and should) get to by googling "Wailord Pringles." Look, we did it for you, . Anyway, we're on that show this week as well, talking about Pokemon for a couple of hours. If you're the kind of person who listens to our show and thinks "man oh man, I wish they would just shut up about comics and get back to Pokemon!" (like I would be, if I listened to our show) then this is the show for you! If you're one of those people who merely tolerates our Pokemon talk, or even has complained about it in the comments or in email, then this is probably not the show for you, but we encourage you to download it anyway even if you have no intention of listening to it - just to make us look more influential than we are. Just download it and delete it, they'll never know. Unless they read this. Which they probably will. SHIT I SHOULD NOT HAVE EATEN THE BACKSPACE KEY ON THIS KEYBOARDE. Big wins this week for Generation Hope #8, Sweet Tooth #23, Secret Six #35, Spider Girl #8, Irredeemable #27 (and part of #26 - you'll see) and Thunderbolts #160. Plus despite some serious love for both Flashpoint and Fear Itself, we've got some ... issues. (one of which is too many damn Juggernauts. The other - we probably shouldn't describe here.) As always, leave your comments or picks on and if you like the show!
This episode of the Awesomed By Comics Podcast is brought to you by the fact that you can pay Nick Spencer three bucks or some 80 year-old painter a lot more (we're assuming) for basically the same idea. Great week for some old-school avenging, some classic X-Mens bantering, some Harley bitchery, and goddamnit, why isn't Bruce Wayne building schools and funding fire departments and neighborhood watch organizations and whatnot? Also despite that Prelude to Schism will make us "understand what leads to the Schism that is coming!" why does it do no such thing? Also why does Montreal hate Pokemon? Also who is "Safeword?" Also should we get the Ocarina of Time 3DS remake? Or should Evie play it on the Wii? OR should we go get the N64 from the basement? SO MANY QUESTIONS HALP!! As always, leave your comments or picks on (where you can also see a picture and get the recipe for Pasta and Vegetables!) and if you like the show!
© 2020-2025 Ivy Podcast Discovery LLC
